Multiple Sclerosis

• FDA label_change · 2009-08-20
  FDA Approved: MITOXANTRONE — Supplemental Application (Hospira, Inc.)

  FDA approved a supplemental application for MITOXANTRONE by Hospira, Inc., resulting in updated labeling for the product under the ANDA. The…

• FDA label_change · 2007-07-18
  FDA Approved: BETASERON — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  FDA approved a supplemental application for Betaseron (interferon beta-1b) from Bayer HealthCare Pharmaceuticals, typically involving labeli…